MDM2 and acute myeloid leukemia: In acute myeloid leukemia (AML), P53 pathway dysregulation occurs through various mechanisms [26, 27], with less than a quarter of AML cases being due to changes in the TP53 gene itself, while others involve downregulation through other mechanisms, such as increased MDM2 activity.